Scroll to top

Scroll to top

Skip to content

Home
About
Pipeline
News
Publications
Investors
Career
Contact

Home
About
Pipeline
News
Publications
Investors
Career
Contact

SEC Filings

Home
Investors
Financials and SEC Filings
SEC Filings

Investor Relations

IR Home
News Releases
Events and Presentations
Stock Information
Financials and SEC Filings
Corporate Governance
IR Contact

SEC Filings

NASDAQIMUX

YearTrailing 12-Months Calendar Year 2024 Calendar Year 2023 Calendar Year 2022 Calendar Year 2021 Calendar Year 2020 Calendar Year 2019

ViewAll Filings Annual Filings Quarterly Filings Current Filings Registration Statements Section 16 Proxy & Information Statements Other

Form	Description	Date	Format

Immunic, Inc.

1200 Avenue of the Americas
Suite 200
New York, NY 10036, USA

Phone: +1 332 2559811
Email: info@imux.com

Immunic AG

Lochhamer Schlag 21
82166 Gräfelfing
Germany

Phone: +49 89 2080 477 00
Email: info@imux.com

Stay in Touch

Contact Us

About
Pipeline

Vidofludimus Calcium
IMU-856
IMU-381

News
Publications
Investors

Career
Contact
Legal Notice

Accessibility Statement
Privacy Policy
Change Privacy Settings

© 2024, Immunic Therapeutics

All rights reserved.